September 16, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link  for your convenience.

NRG Oncology highlighted at #ASTRO19 with 4 Plenary Session talks featuring NRG Oncology resarch. Read more

 


CLOSURES AND SUSPENSIONS

BREAST

NRG-BR002: Temporarily closed to accrual, effective September 13, 2019. Please refer to the memo posted on CTSU for further details.

 

RTOG 1119: Study Closure Memorandum dated September 12, 2019 (posted to CTSU)

 

AMENDMENTS

GENITOURINARY

NRG-GU006 Sites in Canada only: Amendment 3 has been approved by Health Canada. The NOL and relevant forms are posted on the CTSU website. In addition, please be sure to complete and submit the updated IB and protocol signature pages to CTSU.

 

OTHER PROTOCOL NOTICES

1. GYNECOLOGIC

NRG-GY005: CEC Whole Blood Shipping Address memo (posted on CTSU)


NRG-GY009: Block Submission Reminder memo (posted on CTSU)

 

NRG-GY018: Kit Ordering memo (posted on CTSU)


Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more

 

2. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for Wednesday, October 9.

 

 

DRUG SAFETY UPDATES

Safety updates have been issued for the following studies:

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

Pembrolizumab

NRG-GI002

NRG-HN003

NRG-GY016

NRG-GY018

CTSU

CTSU

CTSU

CTSU

Nivolumab

NRG-HN003

NRG

Ipilimumab

NRG-HN003

NRG

 

NRG Oncology at #ASTRO19

Results from twenty-one NRG Oncology clinical trials are being presented at the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago, Illinois being held September 15-18. All four ASTRO Plenary Session presentations are featuring NRG Oncology research, and these four highly impactful projects were chosen from over 3,000 submitted abstracts. The NRG Oncology presentations at the meeting will include results from trials for patients with brain tumors, spine metastases, or anal, breast, cervix, genitourinary, gynecologic, head and neck, liver, lung, or prostate cancer. Read more

 

 

PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain

International Gynecologic Cancer Society (IGCS); Sep 19-20, 2019; Rio de Janeiro, Brazil

International Society for Quality of Life Research (ISOQOL); Oct 20-23, 2019; San Diego, CA

Upcoming Abstract Submission Deadlines

American Association for Thoracic Surgery (AATS); Apr 25-28, 2020; New York, NY; due to publications committee Oct 1, 2019; meeting submission deadline Oct 15, 2019

American Society of Clinical Oncology (ASCO) GI; Jan 23-25, 2020; San Francisco, CA; due to publications committee Sep 17, 2019; meeting submission deadline Oct 1, 2019

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2020; San Francisco, CA; due to publications committee Oct 8, 2019; meeting submission deadline Oct 22, 2019

Society of Gynecologic Oncology (SGO); Mar 28-31, 2020; Toronto, ON Canada; meeting submission deadline Sep 17, 2019; Intl abstr  11-5-19; LBA 1-7-20

Society of Surgical Oncology (SSO); Mar 25-28, 2020; Boston, MA; due to publications committee Sep 16, 2019; meeting submission deadline Oct 7, 2019

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent to shepardm@nrgoncology.org by NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe from all mailings Unsubscribe | Manage Subscription | Forward Email | Report Abuse